Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_assertion type Assertion NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_head.
- NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_assertion description "[Immunohistochemical detection of expression of the epidermal growth factor receptor (EGFR) has been utilized to identify eligible patients with solid malignant tumors, including colorectal adenocarcinoma, for monoclonal antibody therapy (eg, cetuximab).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_provenance.
- NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_assertion evidence source_evidence_literature NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_provenance.
- NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_assertion SIO_000772 16648870 NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_provenance.
- NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_assertion wasDerivedFrom befree-2016 NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_provenance.
- NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_assertion wasGeneratedBy ECO_0000203 NP547587.RAj_9GDLgtiYOSX942ukSKDVX06cXblBmOZv13_a1umyk130_provenance.